[1] Lindemann A, Takahashi H, Patel AA, et al. Targeting the DNA damage response in OSCC with TP53 mutations [J]. J Dent Res, 2018, 97(6):635-644. [2] Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma [J]. Int J Mol Sci, 2018, 19(8):2413. [3] Xiang Y, Guo Z, Zhu P, et al. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science [J]. Cancer Med, 2019, 8(5):1958-1975. [4] Liu Q, Hodge J, Wang J, et al. Emodin reduces breast cancer lung metastasis by suppressing macrophage-induced breast cancer cell epithelial-mesenchymal transition and cancer stem cell formation [J]. Theranostics, 2020, 10(18):8365-8381. [5] Kim YS, Lee YM, Oh TI, et al. Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism [J]. Int J Mol Sci, 2018, 19(10):3127. [6] Saunders IT, Mir H, Kapur N, et al. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways [J]. Cancer Cell Int, 2019, 19:98. [7] Wen J, Yin P, Li L, et al. Knockdown of matrix metallopeptidase 9 inhibits metastasis of oral squamous cell carcinoma cells in a zebrafish xenograft model [J]. Biomed Res Int, 2020, 2020:4350783. [8] Dong X, Fu J, Yin X, et al. Emodin: A review of its pharmacology, toxicity and pharmacokinetics [J]. Phytother Res, 2016, 30(8):1207-1218. [9] Shrimali D, Shanmugam MK, Kumar AP, et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer [J]. Cancer Lett, 2013, 341(2):139-149. [10] Gobin E, Bagwell K, Wagner J, et al. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential [J]. BMC Cancer, 2019, 19(1):581. [11] 杨勇涛,杨宏宇,王宇帆,等.尿路上皮癌胚抗原1对口腔癌细胞侵袭迁移及增殖影响的实验研究[J].中华口腔医学杂志,2016,51(1):36-41. [12] Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, et al. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma [J]. Oncol Lett, 2020, 19(4):3011-3020. [13] 周雄明,那思家,潘淑婷,等.白花丹素对舌鳞状细胞癌细胞的侵袭和迁移的作用及机制研究[J].口腔医学研究,2018,34(1):39-43. [14] Fang Z, Zhao J, Xie W, et al. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression [J]. Cancer Med, 2017, 6(12):2897-2908. [15] Wu H, Chen W, Li G, et al. Analysis of the differentially expressed genes induced by cisplatin resistance in oral squamous cell carcinomas and their interaction [J]. Front Genet, 2020, 10:1328. [16] 宋琳婧,张培先,龙轶,等.紫杉醇联合顺铂化疗对口腔癌患者外周血细胞免疫的影响分析[J].世界临床医学,2019,13(2):91-92. [17] Chen S, Zhang Z, Zhang J. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo [J]. Drug Des Devel Ther, 2019, 13:1145-1153. [18] Li T, Si W, Zhu J, et al. Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway [J]. Am J Transl Res, 2020, 12(5):1851-1861. |